Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility? Mendoza Ladrón De Guevara, Nicolás Quereda, Francisco Female sexual dysfunction Genitourinary syndrome of menopause Dyspareunia Solid-state vaginal laser Epidermal growth factor Objective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Mechanism: Narrative review on non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Findings in Brief: Dyspareunia is the most bothersome symptom of the genitourinary syndrome of menopause, often complicated by decreased sexual interest and arousal. Solid-state vaginal laser (SSVL) and recombinant plateletderived epidermal growth factors (RGFs) are new alternatives are new alternatives that improve female sexual dysfunction resulting from dyspareunia. Conclusions: SSVL is a new alternative the treatment of postmenopausal dyspareunia either alone or in combination with other alternatives with efficacy and safety similar to the classical options. 2023-07-20T08:03:02Z 2023-07-20T08:03:02Z 2023-02-08 info:eu-repo/semantics/article Mendoza, N., & Quereda, F. (2023). Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility?. Clinical and Experimental Obstetrics & Gynecology, 50(2), 40. [https://doi.org/10.31083/j.ceog5002040] https://hdl.handle.net/10481/83885 doi.org/10.31083/j.ceog5002040 eng http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess Atribución 4.0 Internacional IMR Press